ERBB2 and gastric cancer: Clinical research on CAR‐M is still at an early stage with three ongoing studies (NCT05007379, NCT04660929, and NCT06224738), including a 2024 study that explores Human HER2‐targeted CAR‐M for HER2‐positive advanced gastric cancer with peritoneal metastases.